Markets:

Overview

News

Currencies

International

Treasuries

ImmunoGen, Inc. - Common Stock (NQ:IMGN)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 9, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about ImmunoGen, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday ↗

November 16, 2022

Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday.

Via Benzinga

Short Volatility Alert: ImmunoGen, Inc. ↗

August 31, 2022

On Tuesday, shares of ImmunoGen, Inc. (NASDAQ: IMGN) experienced volatile short activity. After the activity, the stock price went down -0.86% to $5.75. The overall sentiment for IMGN has been...

Via Benzinga

Recap: Immunogen Q2 Earnings ↗

July 29, 2022

Immunogen (NASDAQ:IMGN) reported its Q2 earnings results on Friday, July 29, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Vodafone, Getty Images Holdings, Haynes International And Some Other Big Stocks Moving Lower On Tuesday ↗

November 15, 2022

U.S. stocks traded higher, with the Nasdaq gaining more than 200 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

PDS Biotechnology To Rally Around 129%? Here Are 5 Other Price Target Changes For Tuesday ↗

November 15, 2022

Via Benzinga

HUYA, Tencent Music Entertainment, Taiwan Semiconductor Manufacturing, And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

November 15, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

FDA Grants Conditional Approval To First Antibody Drug Conjugate From ImmunoGen For Pretreated Ovarian Cancer ↗

November 15, 2022

Via Benzinga

Immunogen: Q1 Earnings Insights ↗

May 06, 2022

Immunogen (NASDAQ:IMGN) reported its Q1 earnings results on Friday, May 6, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Recap: Immunogen Q3 Earnings ↗

November 04, 2022

Immunogen (NASDAQ:IMGN) reported its Q3 earnings results on Friday, November 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings Immunogen missed estimated earnings...

Via Benzinga

Earnings Scheduled For November 4, 2022 ↗

November 04, 2022

Companies Reporting Before The Bell • Sprott (NYSE:SII) is likely to report quarterly earnings at $0.49 per share on revenue of $49.95 million. • Telefonica (NYSE:TEF) is likely to report earnings for...

Via Benzinga

Preview: Immunogen's Earnings ↗

November 03, 2022

Immunogen (NASDAQ:IMGN) is set to give its latest quarterly earnings report on Friday, 2022-11-04. Here's what investors need to know before the announcement. Analysts estimate that Immunogen will...

Via Benzinga

Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know ↗

November 01, 2022

October proved to be a mixed month for the Food and Drug Administration’s regulatory decisions. Two new molecular entities, or NMEs, were approved during the month, bringing the tally for the...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 29, 2022

Via Benzinga

Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update ↗

July 29, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022 ↗

September 09, 2022

Upgrades

Via Benzinga

Earnings Preview For Immunogen ↗

July 28, 2022

Immunogen (NASDAQ:IMGN) is set to give its latest quarterly earnings report on Friday, 2022-07-29. Here's what investors need to know before the announcement. Analysts estimate that Immunogen will...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 19, 2022

Gainers Talis Biomedical (NASDAQ:TLIS) shares moved upwards by 10.6% to $0.94 during Tuesday's after-market session. The company's market cap stands at $25.0 million.

Via Benzinga

Earnings Scheduled For July 29, 2022 ↗

July 29, 2022

Companies Reporting Before The Bell • Capital Product Partners (NASDAQ:CPLP) is expected to report quarterly earnings at $1.13 per share on revenue of $72.73 million.

Via Benzinga

Immunogen's Return On Capital Employed Overview ↗

May 31, 2022

According to Benzinga Pro data, during Q1, Immunogen (NASDAQ:IMGN) posted sales of $38.08 million. Earnings were up 35.05%, but Immunogen still reported an overall loss of $24.14 million.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 27, 2022

Via Benzinga

What's Going On With ImmunoGen Shares Today? ↗

May 23, 2022

ImmunoGen, Inc. (NASDAQ: IMGN) shares are trading flat at $3.57 after the company's Biologics License Application to treat ovarian cancer was accepted by the FDA with priority review.

Via Benzinga

Earnings Scheduled For May 6, 2022 ↗

May 06, 2022

Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEP) is expected to report quarterly loss at $0.02 per share on revenue of $1.27 billion.

Via Benzinga

Immunogen Earnings Preview ↗

May 05, 2022

Immunogen (NASDAQ:IMGN) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that Immunogen will...

Via Benzinga

The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More ↗

May 02, 2022

Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 14, 2022

Gainers

Via Benzinga

The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia ↗

March 29, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

75 Biggest Movers From Yesterday ↗

March 22, 2022

Gainers NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) shares jumped 299.4% to close at $6.23 on Monday as the company received clearance from the FDA to initiate a pharmacokinetic...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 21, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

March 21, 2022

During Monday's session, 39 stocks hit new 52-week lows. Interesting Facts About Today's 52-Week Lows: The largest company in terms of market cap to set a...

Via Benzinga

46 Stocks Moving In Monday's Mid-Day Session ↗

March 21, 2022

Gainers NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) climbed 369% to $7.32 as the company received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

ImmunoGen, Inc. - Common Stock (NQ:IMGN)

Headline News about ImmunoGen, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today